Rage Against The Machine: Generics CEOs Slam Systemic Problems In The US
PBMs, Rebates, Tariffs, And Reshoring Come Under Fire From Industry Leaders
During the “CEOs Unplugged” panel at the AAM’s annual conference in February, leaders from Sandoz, Lupin and Amneal discussed the various ways in which the US framework is making life difficult for generics and biosimilars.
